nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2D6—Fingolimod—multiple sclerosis	0.131	0.189	CbGbCtD
Desloratadine—ABCB1—Methylprednisolone—multiple sclerosis	0.0894	0.129	CbGbCtD
Desloratadine—CYP2C19—Prednisone—multiple sclerosis	0.0671	0.097	CbGbCtD
Desloratadine—ABCB1—Mitoxantrone—multiple sclerosis	0.0652	0.0943	CbGbCtD
Desloratadine—ABCB1—Betamethasone—multiple sclerosis	0.0581	0.084	CbGbCtD
Desloratadine—ABCB1—Prednisolone—multiple sclerosis	0.0574	0.0829	CbGbCtD
Desloratadine—ABCB1—Prednisone—multiple sclerosis	0.0542	0.0783	CbGbCtD
Desloratadine—CYP2C19—Dexamethasone—multiple sclerosis	0.0419	0.0606	CbGbCtD
Desloratadine—CYP2C9—Dexamethasone—multiple sclerosis	0.0348	0.0504	CbGbCtD
Desloratadine—ABCB1—Dexamethasone—multiple sclerosis	0.0338	0.0489	CbGbCtD
Desloratadine—CYP2D6—Dexamethasone—multiple sclerosis	0.0319	0.0461	CbGbCtD
Desloratadine—ABCB1—Methotrexate—multiple sclerosis	0.0272	0.0393	CbGbCtD
Desloratadine—Cough—Mitoxantrone—multiple sclerosis	0.00072	0.00245	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000719	0.00244	CcSEcCtD
Desloratadine—Convulsion—Mitoxantrone—multiple sclerosis	0.000715	0.00243	CcSEcCtD
Desloratadine—Hallucination—Methylprednisolone—multiple sclerosis	0.00071	0.00241	CcSEcCtD
Desloratadine—Pharyngitis—Triamcinolone—multiple sclerosis	0.00071	0.00241	CcSEcCtD
Desloratadine—Myalgia—Mitoxantrone—multiple sclerosis	0.000703	0.00239	CcSEcCtD
Desloratadine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000701	0.00238	CcSEcCtD
Desloratadine—Diarrhoea—Cladribine—multiple sclerosis	0.000701	0.00238	CcSEcCtD
Desloratadine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000681	0.00231	CcSEcCtD
Desloratadine—Dizziness—Cladribine—multiple sclerosis	0.000678	0.0023	CcSEcCtD
Desloratadine—Erythema—Prednisolone—multiple sclerosis	0.000677	0.0023	CcSEcCtD
Desloratadine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000674	0.00229	CcSEcCtD
Desloratadine—Oedema—Mitoxantrone—multiple sclerosis	0.000674	0.00229	CcSEcCtD
Desloratadine—Infection—Mitoxantrone—multiple sclerosis	0.000669	0.00227	CcSEcCtD
Desloratadine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000662	0.00225	CcSEcCtD
Desloratadine—Abdominal pain—Azathioprine—multiple sclerosis	0.000659	0.00224	CcSEcCtD
Desloratadine—Body temperature increased—Azathioprine—multiple sclerosis	0.000659	0.00224	CcSEcCtD
Desloratadine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000657	0.00223	CcSEcCtD
Desloratadine—Irritability—Methotrexate—multiple sclerosis	0.000652	0.00221	CcSEcCtD
Desloratadine—Vomiting—Cladribine—multiple sclerosis	0.000652	0.00221	CcSEcCtD
Desloratadine—Mood swings—Methotrexate—multiple sclerosis	0.000647	0.0022	CcSEcCtD
Desloratadine—Rash—Cladribine—multiple sclerosis	0.000646	0.00219	CcSEcCtD
Desloratadine—Hallucination—Dexamethasone—multiple sclerosis	0.000646	0.00219	CcSEcCtD
Desloratadine—Hallucination—Betamethasone—multiple sclerosis	0.000646	0.00219	CcSEcCtD
Desloratadine—Dermatitis—Cladribine—multiple sclerosis	0.000646	0.00219	CcSEcCtD
Desloratadine—Anorexia—Mitoxantrone—multiple sclerosis	0.000642	0.00218	CcSEcCtD
Desloratadine—Headache—Cladribine—multiple sclerosis	0.000642	0.00218	CcSEcCtD
Desloratadine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000625	0.00212	CcSEcCtD
Desloratadine—Erythema—Triamcinolone—multiple sclerosis	0.000623	0.00211	CcSEcCtD
Desloratadine—Erythema—Methylprednisolone—multiple sclerosis	0.000621	0.00211	CcSEcCtD
Desloratadine—Angioedema—Prednisolone—multiple sclerosis	0.000619	0.0021	CcSEcCtD
Desloratadine—Breast disorder—Methotrexate—multiple sclerosis	0.000617	0.0021	CcSEcCtD
Desloratadine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000614	0.00209	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000614	0.00208	CcSEcCtD
Desloratadine—Nausea—Cladribine—multiple sclerosis	0.000609	0.00207	CcSEcCtD
Desloratadine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.0006	0.00204	CcSEcCtD
Desloratadine—Somnolence—Mitoxantrone—multiple sclerosis	0.000599	0.00203	CcSEcCtD
Desloratadine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000593	0.00201	CcSEcCtD
Desloratadine—Convulsion—Prednisolone—multiple sclerosis	0.000587	0.00199	CcSEcCtD
Desloratadine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000586	0.00199	CcSEcCtD
Desloratadine—Fatigue—Mitoxantrone—multiple sclerosis	0.000581	0.00197	CcSEcCtD
Desloratadine—Diarrhoea—Azathioprine—multiple sclerosis	0.00057	0.00194	CcSEcCtD
Desloratadine—Angioedema—Triamcinolone—multiple sclerosis	0.000569	0.00193	CcSEcCtD
Desloratadine—Angioedema—Methylprednisolone—multiple sclerosis	0.000568	0.00193	CcSEcCtD
Desloratadine—Erythema—Betamethasone—multiple sclerosis	0.000565	0.00192	CcSEcCtD
Desloratadine—Erythema—Dexamethasone—multiple sclerosis	0.000565	0.00192	CcSEcCtD
Desloratadine—Hallucination—Prednisone—multiple sclerosis	0.000562	0.00191	CcSEcCtD
Desloratadine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000555	0.00189	CcSEcCtD
Desloratadine—Oedema—Prednisolone—multiple sclerosis	0.000553	0.00188	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000553	0.00188	CcSEcCtD
Desloratadine—Dizziness—Azathioprine—multiple sclerosis	0.000551	0.00187	CcSEcCtD
Desloratadine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000551	0.00187	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000548	0.00186	CcSEcCtD
Desloratadine—Cough—Triamcinolone—multiple sclerosis	0.000543	0.00185	CcSEcCtD
Desloratadine—Convulsion—Triamcinolone—multiple sclerosis	0.000539	0.00183	CcSEcCtD
Desloratadine—Tachycardia—Prednisolone—multiple sclerosis	0.000539	0.00183	CcSEcCtD
Desloratadine—Convulsion—Methylprednisolone—multiple sclerosis	0.000538	0.00183	CcSEcCtD
Desloratadine—Urticaria—Mitoxantrone—multiple sclerosis	0.000535	0.00182	CcSEcCtD
Desloratadine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000532	0.00181	CcSEcCtD
Desloratadine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000532	0.00181	CcSEcCtD
Desloratadine—Myalgia—Triamcinolone—multiple sclerosis	0.00053	0.0018	CcSEcCtD
Desloratadine—Vomiting—Azathioprine—multiple sclerosis	0.00053	0.0018	CcSEcCtD
Desloratadine—Myalgia—Methylprednisolone—multiple sclerosis	0.000529	0.0018	CcSEcCtD
Desloratadine—Infestation—Methotrexate—multiple sclerosis	0.000526	0.00179	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—multiple sclerosis	0.000526	0.00179	CcSEcCtD
Desloratadine—Rash—Azathioprine—multiple sclerosis	0.000525	0.00178	CcSEcCtD
Desloratadine—Dermatitis—Azathioprine—multiple sclerosis	0.000525	0.00178	CcSEcCtD
Desloratadine—Headache—Azathioprine—multiple sclerosis	0.000522	0.00177	CcSEcCtD
Desloratadine—Dry mouth—Triamcinolone—multiple sclerosis	0.000518	0.00176	CcSEcCtD
Desloratadine—Angioedema—Dexamethasone—multiple sclerosis	0.000516	0.00175	CcSEcCtD
Desloratadine—Angioedema—Betamethasone—multiple sclerosis	0.000516	0.00175	CcSEcCtD
Desloratadine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000508	0.00173	CcSEcCtD
Desloratadine—Oedema—Triamcinolone—multiple sclerosis	0.000508	0.00173	CcSEcCtD
Desloratadine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000507	0.00172	CcSEcCtD
Desloratadine—Infection—Triamcinolone—multiple sclerosis	0.000505	0.00171	CcSEcCtD
Desloratadine—Infection—Methylprednisolone—multiple sclerosis	0.000504	0.00171	CcSEcCtD
Desloratadine—Insomnia—Prednisolone—multiple sclerosis	0.0005	0.0017	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000498	0.00169	CcSEcCtD
Desloratadine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000497	0.00169	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—multiple sclerosis	0.000496	0.00169	CcSEcCtD
Desloratadine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000496	0.00169	CcSEcCtD
Desloratadine—Tachycardia—Triamcinolone—multiple sclerosis	0.000496	0.00168	CcSEcCtD
Desloratadine—Mental disorder—Prednisone—multiple sclerosis	0.000495	0.00168	CcSEcCtD
Desloratadine—Nausea—Azathioprine—multiple sclerosis	0.000495	0.00168	CcSEcCtD
Desloratadine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000495	0.00168	CcSEcCtD
Desloratadine—Erythema—Prednisone—multiple sclerosis	0.000492	0.00167	CcSEcCtD
Desloratadine—Convulsion—Dexamethasone—multiple sclerosis	0.00049	0.00166	CcSEcCtD
Desloratadine—Convulsion—Betamethasone—multiple sclerosis	0.00049	0.00166	CcSEcCtD
Desloratadine—Asthenia—Mitoxantrone—multiple sclerosis	0.000483	0.00164	CcSEcCtD
Desloratadine—Myalgia—Betamethasone—multiple sclerosis	0.000481	0.00163	CcSEcCtD
Desloratadine—Myalgia—Dexamethasone—multiple sclerosis	0.000481	0.00163	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—multiple sclerosis	0.000472	0.0016	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—multiple sclerosis	0.000469	0.00159	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000463	0.00157	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000462	0.00157	CcSEcCtD
Desloratadine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000461	0.00157	CcSEcCtD
Desloratadine—Oedema—Dexamethasone—multiple sclerosis	0.000461	0.00157	CcSEcCtD
Desloratadine—Oedema—Betamethasone—multiple sclerosis	0.000461	0.00157	CcSEcCtD
Desloratadine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000461	0.00157	CcSEcCtD
Desloratadine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000461	0.00157	CcSEcCtD
Desloratadine—Insomnia—Triamcinolone—multiple sclerosis	0.00046	0.00156	CcSEcCtD
Desloratadine—Insomnia—Methylprednisolone—multiple sclerosis	0.000459	0.00156	CcSEcCtD
Desloratadine—Infection—Dexamethasone—multiple sclerosis	0.000458	0.00156	CcSEcCtD
Desloratadine—Infection—Betamethasone—multiple sclerosis	0.000458	0.00156	CcSEcCtD
Desloratadine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000453	0.00154	CcSEcCtD
Desloratadine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000452	0.00154	CcSEcCtD
Desloratadine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000452	0.00154	CcSEcCtD
Desloratadine—Agitation—Prednisone—multiple sclerosis	0.000452	0.00154	CcSEcCtD
Desloratadine—Tachycardia—Betamethasone—multiple sclerosis	0.00045	0.00153	CcSEcCtD
Desloratadine—Tachycardia—Dexamethasone—multiple sclerosis	0.00045	0.00153	CcSEcCtD
Desloratadine—Angioedema—Prednisone—multiple sclerosis	0.00045	0.00153	CcSEcCtD
Desloratadine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000447	0.00152	CcSEcCtD
Desloratadine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000446	0.00152	CcSEcCtD
Desloratadine—Anorexia—Dexamethasone—multiple sclerosis	0.00044	0.00149	CcSEcCtD
Desloratadine—Anorexia—Betamethasone—multiple sclerosis	0.00044	0.00149	CcSEcCtD
Desloratadine—Urticaria—Prednisolone—multiple sclerosis	0.000439	0.00149	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000438	0.00149	CcSEcCtD
Desloratadine—Fatigue—Triamcinolone—multiple sclerosis	0.000438	0.00149	CcSEcCtD
Desloratadine—Fatigue—Methylprednisolone—multiple sclerosis	0.000437	0.00148	CcSEcCtD
Desloratadine—Vomiting—Mitoxantrone—multiple sclerosis	0.000428	0.00145	CcSEcCtD
Desloratadine—Convulsion—Prednisone—multiple sclerosis	0.000426	0.00145	CcSEcCtD
Desloratadine—Rash—Mitoxantrone—multiple sclerosis	0.000425	0.00144	CcSEcCtD
Desloratadine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000424	0.00144	CcSEcCtD
Desloratadine—Headache—Mitoxantrone—multiple sclerosis	0.000422	0.00143	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00042	0.00143	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00042	0.00143	CcSEcCtD
Desloratadine—Myalgia—Prednisone—multiple sclerosis	0.000419	0.00142	CcSEcCtD
Desloratadine—Insomnia—Betamethasone—multiple sclerosis	0.000417	0.00142	CcSEcCtD
Desloratadine—Insomnia—Dexamethasone—multiple sclerosis	0.000417	0.00142	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000415	0.00141	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—multiple sclerosis	0.000414	0.00141	CcSEcCtD
Desloratadine—Erythema—Methotrexate—multiple sclerosis	0.000411	0.0014	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000407	0.00138	CcSEcCtD
Desloratadine—Dyspepsia—Betamethasone—multiple sclerosis	0.000406	0.00138	CcSEcCtD
Desloratadine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000406	0.00138	CcSEcCtD
Desloratadine—Urticaria—Triamcinolone—multiple sclerosis	0.000404	0.00137	CcSEcCtD
Desloratadine—Urticaria—Methylprednisolone—multiple sclerosis	0.000403	0.00137	CcSEcCtD
Desloratadine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000402	0.00136	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000402	0.00136	CcSEcCtD
Desloratadine—Oedema—Prednisone—multiple sclerosis	0.000402	0.00136	CcSEcCtD
Desloratadine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000401	0.00136	CcSEcCtD
Desloratadine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000401	0.00136	CcSEcCtD
Desloratadine—Decreased appetite—Betamethasone—multiple sclerosis	0.000401	0.00136	CcSEcCtD
Desloratadine—Nausea—Mitoxantrone—multiple sclerosis	0.0004	0.00136	CcSEcCtD
Desloratadine—Infection—Prednisone—multiple sclerosis	0.000399	0.00136	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000398	0.00135	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000398	0.00135	CcSEcCtD
Desloratadine—Fatigue—Dexamethasone—multiple sclerosis	0.000398	0.00135	CcSEcCtD
Desloratadine—Fatigue—Betamethasone—multiple sclerosis	0.000398	0.00135	CcSEcCtD
Desloratadine—Nervous system disorder—Prednisone—multiple sclerosis	0.000394	0.00134	CcSEcCtD
Desloratadine—Tachycardia—Prednisone—multiple sclerosis	0.000392	0.00133	CcSEcCtD
Desloratadine—Anorexia—Prednisone—multiple sclerosis	0.000383	0.0013	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000377	0.00128	CcSEcCtD
Desloratadine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000377	0.00128	CcSEcCtD
Desloratadine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000374	0.00127	CcSEcCtD
Desloratadine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000374	0.00127	CcSEcCtD
Desloratadine—Urticaria—Betamethasone—multiple sclerosis	0.000366	0.00124	CcSEcCtD
Desloratadine—Urticaria—Dexamethasone—multiple sclerosis	0.000366	0.00124	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000366	0.00124	CcSEcCtD
Desloratadine—Dizziness—Prednisolone—multiple sclerosis	0.000365	0.00124	CcSEcCtD
Desloratadine—Asthenia—Triamcinolone—multiple sclerosis	0.000365	0.00124	CcSEcCtD
Desloratadine—Abdominal pain—Betamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Desloratadine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Desloratadine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Desloratadine—Body temperature increased—Betamethasone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Desloratadine—Asthenia—Methylprednisolone—multiple sclerosis	0.000364	0.00124	CcSEcCtD
Desloratadine—Insomnia—Prednisone—multiple sclerosis	0.000363	0.00123	CcSEcCtD
Desloratadine—Pruritus—Triamcinolone—multiple sclerosis	0.00036	0.00122	CcSEcCtD
Desloratadine—Cough—Methotrexate—multiple sclerosis	0.000359	0.00122	CcSEcCtD
Desloratadine—Pruritus—Methylprednisolone—multiple sclerosis	0.000359	0.00122	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—multiple sclerosis	0.000356	0.00121	CcSEcCtD
Desloratadine—Dyspepsia—Prednisone—multiple sclerosis	0.000353	0.0012	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—multiple sclerosis	0.00035	0.00119	CcSEcCtD
Desloratadine—Decreased appetite—Prednisone—multiple sclerosis	0.000349	0.00119	CcSEcCtD
Desloratadine—Rash—Prednisolone—multiple sclerosis	0.000348	0.00118	CcSEcCtD
Desloratadine—Dermatitis—Prednisolone—multiple sclerosis	0.000348	0.00118	CcSEcCtD
Desloratadine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000347	0.00118	CcSEcCtD
Desloratadine—Fatigue—Prednisone—multiple sclerosis	0.000346	0.00118	CcSEcCtD
Desloratadine—Headache—Prednisolone—multiple sclerosis	0.000346	0.00118	CcSEcCtD
Desloratadine—Dizziness—Triamcinolone—multiple sclerosis	0.000336	0.00114	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000336	0.00114	CcSEcCtD
Desloratadine—Dizziness—Methylprednisolone—multiple sclerosis	0.000335	0.00114	CcSEcCtD
Desloratadine—Infection—Methotrexate—multiple sclerosis	0.000333	0.00113	CcSEcCtD
Desloratadine—Asthenia—Betamethasone—multiple sclerosis	0.000331	0.00112	CcSEcCtD
Desloratadine—Asthenia—Dexamethasone—multiple sclerosis	0.000331	0.00112	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000329	0.00112	CcSEcCtD
Desloratadine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000328	0.00112	CcSEcCtD
Desloratadine—Nausea—Prednisolone—multiple sclerosis	0.000328	0.00111	CcSEcCtD
Desloratadine—Pruritus—Betamethasone—multiple sclerosis	0.000326	0.00111	CcSEcCtD
Desloratadine—Pruritus—Dexamethasone—multiple sclerosis	0.000326	0.00111	CcSEcCtD
Desloratadine—Vomiting—Triamcinolone—multiple sclerosis	0.000323	0.0011	CcSEcCtD
Desloratadine—Vomiting—Methylprednisolone—multiple sclerosis	0.000322	0.0011	CcSEcCtD
Desloratadine—Rash—Triamcinolone—multiple sclerosis	0.00032	0.00109	CcSEcCtD
Desloratadine—Dermatitis—Triamcinolone—multiple sclerosis	0.00032	0.00109	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—multiple sclerosis	0.00032	0.00109	CcSEcCtD
Desloratadine—Rash—Methylprednisolone—multiple sclerosis	0.00032	0.00109	CcSEcCtD
Desloratadine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000319	0.00108	CcSEcCtD
Desloratadine—Urticaria—Prednisone—multiple sclerosis	0.000319	0.00108	CcSEcCtD
Desloratadine—Headache—Triamcinolone—multiple sclerosis	0.000318	0.00108	CcSEcCtD
Desloratadine—Headache—Methylprednisolone—multiple sclerosis	0.000318	0.00108	CcSEcCtD
Desloratadine—Body temperature increased—Prednisone—multiple sclerosis	0.000317	0.00108	CcSEcCtD
Desloratadine—Abdominal pain—Prednisone—multiple sclerosis	0.000317	0.00108	CcSEcCtD
Desloratadine—Diarrhoea—Betamethasone—multiple sclerosis	0.000315	0.00107	CcSEcCtD
Desloratadine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000315	0.00107	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000306	0.00104	CcSEcCtD
Desloratadine—Dizziness—Betamethasone—multiple sclerosis	0.000305	0.00104	CcSEcCtD
Desloratadine—Dizziness—Dexamethasone—multiple sclerosis	0.000305	0.00104	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—multiple sclerosis	0.000304	0.00103	CcSEcCtD
Desloratadine—Nausea—Triamcinolone—multiple sclerosis	0.000302	0.00103	CcSEcCtD
Desloratadine—Nausea—Methylprednisolone—multiple sclerosis	0.000301	0.00102	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—multiple sclerosis	0.000299	0.00102	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—multiple sclerosis	0.000298	0.00101	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisone—multiple sclerosis	0.000296	0.001	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—multiple sclerosis	0.000295	0.001	CcSEcCtD
Desloratadine—Vomiting—Betamethasone—multiple sclerosis	0.000293	0.000996	CcSEcCtD
Desloratadine—Vomiting—Dexamethasone—multiple sclerosis	0.000293	0.000996	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—multiple sclerosis	0.000292	0.000991	CcSEcCtD
Desloratadine—Rash—Betamethasone—multiple sclerosis	0.000291	0.000988	CcSEcCtD
Desloratadine—Rash—Dexamethasone—multiple sclerosis	0.000291	0.000988	CcSEcCtD
Desloratadine—Dermatitis—Betamethasone—multiple sclerosis	0.00029	0.000987	CcSEcCtD
Desloratadine—Dermatitis—Dexamethasone—multiple sclerosis	0.00029	0.000987	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00029	0.000984	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—multiple sclerosis	0.000289	0.000983	CcSEcCtD
Desloratadine—Headache—Dexamethasone—multiple sclerosis	0.000289	0.000981	CcSEcCtD
Desloratadine—Headache—Betamethasone—multiple sclerosis	0.000289	0.000981	CcSEcCtD
Desloratadine—Asthenia—Prednisone—multiple sclerosis	0.000288	0.000979	CcSEcCtD
Desloratadine—Pruritus—Prednisone—multiple sclerosis	0.000284	0.000965	CcSEcCtD
Desloratadine—Diarrhoea—Prednisone—multiple sclerosis	0.000275	0.000933	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000274	0.000932	CcSEcCtD
Desloratadine—Nausea—Betamethasone—multiple sclerosis	0.000274	0.00093	CcSEcCtD
Desloratadine—Nausea—Dexamethasone—multiple sclerosis	0.000274	0.00093	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—multiple sclerosis	0.000267	0.000906	CcSEcCtD
Desloratadine—Dizziness—Prednisone—multiple sclerosis	0.000266	0.000902	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—multiple sclerosis	0.000265	0.000901	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—multiple sclerosis	0.000265	0.000901	CcSEcCtD
Desloratadine—Vomiting—Prednisone—multiple sclerosis	0.000255	0.000867	CcSEcCtD
Desloratadine—Rash—Prednisone—multiple sclerosis	0.000253	0.00086	CcSEcCtD
Desloratadine—Dermatitis—Prednisone—multiple sclerosis	0.000253	0.000859	CcSEcCtD
Desloratadine—Headache—Prednisone—multiple sclerosis	0.000252	0.000854	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000247	0.00084	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—multiple sclerosis	0.000241	0.000818	CcSEcCtD
Desloratadine—Nausea—Prednisone—multiple sclerosis	0.000239	0.00081	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—multiple sclerosis	0.000237	0.000806	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—multiple sclerosis	0.00023	0.00078	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—multiple sclerosis	0.000222	0.000754	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—multiple sclerosis	0.000213	0.000725	CcSEcCtD
Desloratadine—Rash—Methotrexate—multiple sclerosis	0.000212	0.000719	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—multiple sclerosis	0.000211	0.000718	CcSEcCtD
Desloratadine—Headache—Methotrexate—multiple sclerosis	0.00021	0.000714	CcSEcCtD
Desloratadine—Nausea—Methotrexate—multiple sclerosis	0.000199	0.000677	CcSEcCtD
Desloratadine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	8.35e-05	0.00608	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.23e-05	0.006	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.23e-05	0.006	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	8.2e-05	0.00597	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	8.19e-05	0.00597	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	8.13e-05	0.00592	CbGpPWpGaD
Desloratadine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.78e-05	0.00567	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	7.68e-05	0.00559	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	7.68e-05	0.00559	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	7.61e-05	0.00554	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	7.61e-05	0.00554	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.57e-05	0.00551	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.57e-05	0.00551	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	7.52e-05	0.00548	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.51e-05	0.00547	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.51e-05	0.00547	CbGpPWpGaD
Desloratadine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	7.18e-05	0.00523	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	7.11e-05	0.00518	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	7.08e-05	0.00516	CbGpPWpGaD
Desloratadine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	7.07e-05	0.00515	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	6.9e-05	0.00503	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	6.61e-05	0.00481	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	6.55e-05	0.00477	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—TYK2—multiple sclerosis	6.52e-05	0.00475	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	6.5e-05	0.00474	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	6.5e-05	0.00474	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	6.47e-05	0.00472	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.41e-05	0.00467	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.41e-05	0.00467	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	6.3e-05	0.00459	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	6.21e-05	0.00452	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	6.07e-05	0.00442	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	5.73e-05	0.00417	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	5.68e-05	0.00413	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	5.55e-05	0.00404	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	5.55e-05	0.00404	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	5.47e-05	0.00398	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	5.12e-05	0.00373	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	4.93e-05	0.00359	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	4.83e-05	0.00352	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	4.83e-05	0.00352	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	4.7e-05	0.00342	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	4.62e-05	0.00336	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	4.6e-05	0.00335	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	4.57e-05	0.00333	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	4.44e-05	0.00323	CbGpPWpGaD
Desloratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.36e-05	0.00318	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	4.33e-05	0.00315	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	4.31e-05	0.00314	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	4.29e-05	0.00312	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	4.26e-05	0.0031	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	4.22e-05	0.00308	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	4.22e-05	0.00308	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	4.17e-05	0.00304	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	4.15e-05	0.00302	CbGpPWpGaD
Desloratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.01e-05	0.00292	CbGpPWpGaD
Desloratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.98e-05	0.0029	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	3.95e-05	0.00288	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	3.89e-05	0.00283	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	3.85e-05	0.0028	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	3.8e-05	0.00277	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	3.67e-05	0.00268	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	3.59e-05	0.00262	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	3.57e-05	0.0026	CbGpPWpGaD
Desloratadine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.53e-05	0.00257	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.5e-05	0.00255	CbGpPWpGaD
Desloratadine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.4e-05	0.00247	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	3.3e-05	0.0024	CbGpPWpGaD
Desloratadine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.25e-05	0.00237	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	3.24e-05	0.00236	CbGpPWpGaD
Desloratadine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.22e-05	0.00235	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.2e-05	0.00233	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.2e-05	0.00233	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.2e-05	0.00233	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	3.12e-05	0.00227	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.11e-05	0.00227	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	3.11e-05	0.00226	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	3.01e-05	0.00219	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	2.97e-05	0.00216	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	2.94e-05	0.00214	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.92e-05	0.00213	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.92e-05	0.00213	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	2.9e-05	0.00211	CbGpPWpGaD
Desloratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.89e-05	0.00211	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.84e-05	0.00207	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	2.8e-05	0.00204	CbGpPWpGaD
Desloratadine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.75e-05	0.00201	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	2.75e-05	0.00201	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	2.72e-05	0.00198	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	2.69e-05	0.00196	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	2.61e-05	0.0019	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	2.56e-05	0.00186	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.53e-05	0.00185	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.52e-05	0.00184	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	2.51e-05	0.00183	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	2.5e-05	0.00182	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.5e-05	0.00182	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.5e-05	0.00182	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.5e-05	0.00182	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.43e-05	0.00177	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.42e-05	0.00177	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.42e-05	0.00176	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	2.39e-05	0.00174	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	2.39e-05	0.00174	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.38e-05	0.00173	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	2.37e-05	0.00173	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.3e-05	0.00168	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	2.29e-05	0.00167	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.26e-05	0.00165	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.26e-05	0.00165	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	2.26e-05	0.00165	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	2.17e-05	0.00158	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	2.17e-05	0.00158	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	2.16e-05	0.00157	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.14e-05	0.00156	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SRM—multiple sclerosis	2.03e-05	0.00148	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	1.99e-05	0.00145	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SRM—multiple sclerosis	1.98e-05	0.00144	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.97e-05	0.00143	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	1.95e-05	0.00142	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.92e-05	0.0014	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.88e-05	0.00137	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SRM—multiple sclerosis	1.86e-05	0.00136	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SRM—multiple sclerosis	1.85e-05	0.00135	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.84e-05	0.00134	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.8e-05	0.00131	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.76e-05	0.00128	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	1.75e-05	0.00128	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	1.74e-05	0.00127	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.73e-05	0.00126	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.71e-05	0.00125	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.69e-05	0.00123	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	1.69e-05	0.00123	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	1.64e-05	0.00119	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	1.58e-05	0.00115	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SRM—multiple sclerosis	1.58e-05	0.00115	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	1.54e-05	0.00113	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	1.54e-05	0.00112	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	1.49e-05	0.00108	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	1.48e-05	0.00108	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.46e-05	0.00107	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	1.44e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.43e-05	0.00104	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.43e-05	0.00104	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	1.42e-05	0.00103	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	1.4e-05	0.00102	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	1.4e-05	0.00102	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.39e-05	0.00102	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.39e-05	0.00101	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.39e-05	0.00101	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	1.37e-05	0.001	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	1.37e-05	0.000999	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	1.34e-05	0.000977	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.31e-05	0.000956	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.31e-05	0.000956	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.31e-05	0.000951	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.3e-05	0.000948	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.3e-05	0.000948	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	1.29e-05	0.000939	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	1.28e-05	0.000933	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	1.28e-05	0.000933	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.28e-05	0.000931	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.27e-05	0.000928	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.27e-05	0.000926	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.2e-05	0.000875	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.19e-05	0.000867	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	1.16e-05	0.000845	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.11e-05	0.00081	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.11e-05	0.00081	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	1.1e-05	0.000801	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.09e-05	0.000792	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.08e-05	0.000788	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.06e-05	0.00077	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.06e-05	0.000769	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.02e-05	0.000741	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	9.99e-06	0.000728	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.95e-06	0.000725	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	9.91e-06	0.000722	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.86e-06	0.000718	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	9.77e-06	0.000712	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.74e-06	0.000709	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.72e-06	0.000708	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.53e-06	0.000694	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	9.13e-06	0.000665	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.07e-06	0.000661	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	9e-06	0.000656	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	8.87e-06	0.000646	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	8.78e-06	0.00064	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PGR—multiple sclerosis	8.65e-06	0.00063	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	8.48e-06	0.000618	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—RRM1—multiple sclerosis	8.43e-06	0.000614	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD28—multiple sclerosis	8.4e-06	0.000612	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.39e-06	0.000611	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	8.25e-06	0.000601	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	7.75e-06	0.000564	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.65e-06	0.000557	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	7.62e-06	0.000555	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.21e-06	0.000525	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	7.04e-06	0.000512	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	6.88e-06	0.000501	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	6.86e-06	0.000499	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.57e-06	0.000479	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.57e-06	0.000479	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.54e-06	0.000476	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	6.25e-06	0.000455	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.21e-06	0.000452	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.1e-06	0.000444	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—BCHE—multiple sclerosis	6.06e-06	0.000442	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD86—multiple sclerosis	6e-06	0.000437	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.99e-06	0.000437	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	5.9e-06	0.00043	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	5.73e-06	0.000417	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.71e-06	0.000416	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.66e-06	0.000413	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.62e-06	0.000409	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	5.47e-06	0.000398	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	5.32e-06	0.000387	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	5.24e-06	0.000382	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	5.2e-06	0.000379	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.12e-06	0.000373	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BCHE—multiple sclerosis	4.84e-06	0.000353	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOE—multiple sclerosis	4.84e-06	0.000352	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD80—multiple sclerosis	4.37e-06	0.000319	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—POMC—multiple sclerosis	4.16e-06	0.000303	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	4.07e-06	0.000296	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	3.98e-06	0.00029	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOE—multiple sclerosis	3.74e-06	0.000272	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	3.69e-06	0.000269	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOE—multiple sclerosis	3.65e-06	0.000266	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOE—multiple sclerosis	3.44e-06	0.00025	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOE—multiple sclerosis	3.41e-06	0.000248	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—POMC—multiple sclerosis	3.21e-06	0.000234	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—POMC—multiple sclerosis	3.13e-06	0.000228	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—multiple sclerosis	3.07e-06	0.000224	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	3.06e-06	0.000223	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—POMC—multiple sclerosis	2.95e-06	0.000215	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.93e-06	0.000213	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—multiple sclerosis	2.93e-06	0.000213	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOE—multiple sclerosis	2.91e-06	0.000212	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	2.91e-06	0.000212	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—multiple sclerosis	2.86e-06	0.000208	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.69e-06	0.000196	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.67e-06	0.000194	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	2.59e-06	0.000188	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—POMC—multiple sclerosis	2.5e-06	0.000182	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—multiple sclerosis	2.4e-06	0.000175	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	2.4e-06	0.000175	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	2.35e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—multiple sclerosis	2.28e-06	0.000166	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—multiple sclerosis	1.81e-06	0.000132	CbGpPWpGaD
